NPI: 1659435840 · CHARLESTON, SC 29425 · General Acute Care Hospital · NPI assigned 12/21/2006
Authorized official RAE, KARYN controls 20+ related entities in our dataset. Read more
| Authorized Official | RAE, KARYN (DIRECTOR) |
| NPI Enumeration Date | 12/21/2006 |
Other providers sharing the same authorized official: RAE, KARYN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 755,908 | $30.13M |
| 2019 | 792,625 | $31.40M |
| 2020 | 705,838 | $30.20M |
| 2021 | 932,459 | $38.72M |
| 2022 | 987,562 | $42.02M |
| 2023 | 894,031 | $38.97M |
| 2024 | 789,996 | $29.98M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 372,199 | 325,941 | $17.58M |
| 80053 | Comprehensive metabolic panel | 169,784 | 132,574 | $16.46M |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 233,261 | 206,779 | $15.46M |
| 36415 | Collection of venous blood by venipuncture | 246,755 | 193,765 | $13.18M |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 52,594 | 27,980 | $9.54M |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 31,096 | 25,609 | $6.78M |
| 80048 | Basic metabolic panel (calcium, ionized) | 75,212 | 57,165 | $5.08M |
| A9585 | Injection, gadobutrol, 0.1 ml | 5,955 | 5,071 | $4.87M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 34,515 | 32,386 | $4.40M |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 52,137 | 50,141 | $4.23M |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 4,405 | 2,871 | $3.97M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 27,001 | 25,348 | $3.92M |
| 86850 | 38,466 | 30,646 | $3.80M | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 25,166 | 18,908 | $3.26M |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 8,115 | 7,812 | $3.13M |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 80,419 | 75,331 | $3.10M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 47,212 | 17,219 | $2.92M |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 23,498 | 16,447 | $2.57M |
| 96375 | Therapeutic injection; each additional sequential IV push | 29,385 | 19,988 | $2.53M |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 8,810 | 8,411 | $2.39M |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 2,407 | 2,317 | $2.17M |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 19,898 | 19,415 | $2.16M |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 35,478 | 13,001 | $2.15M |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 19,240 | 17,628 | $2.07M |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 20,113 | 19,445 | $2.05M |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 7,744 | 7,294 | $1.99M |
| 94010 | 13,625 | 12,991 | $1.79M | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 22,756 | 9,548 | $1.71M |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 3,258 | 3,187 | $1.66M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 15,991 | 14,996 | $1.65M |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 4,980 | 3,248 | $1.65M |
| 95782 | 2,026 | 1,932 | $1.64M | |
| Q3014 | Telehealth originating site facility fee | 49,347 | 44,721 | $1.59M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 58,975 | 51,143 | $1.55M |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 9,358 | 8,616 | $1.53M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 42,819 | 39,740 | $1.42M |
| 83036 | Hemoglobin; glycosylated (A1C) | 47,815 | 44,782 | $1.41M |
| 82947 | 28,661 | 21,212 | $1.40M | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 5,308 | 5,139 | $1.39M |
| 81002 | 10,163 | 8,887 | $1.33M | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 50,602 | 46,585 | $1.26M |
| 86780 | 27,186 | 26,042 | $1.22M | |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | 11,354 | 9,952 | $1.17M |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 17,585 | 14,079 | $1.16M |
| 76819 | Fetal biophysical profile; without non-stress testing | 8,056 | 4,938 | $1.06M |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 16,118 | 15,700 | $1.04M |
| 92567 | 9,416 | 9,017 | $1.01M | |
| 92557 | 5,031 | 4,878 | $974K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 18,567 | 18,173 | $948K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 39,986 | 26,324 | $899K |
| 87070 | 18,588 | 17,322 | $887K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 37,882 | 36,141 | $885K |
| 76770 | 9,834 | 9,501 | $871K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 178,993 | 137,602 | $862K |
| 95813 | 2,545 | 2,490 | $850K | |
| 81025 | 20,256 | 18,994 | $833K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 9,030 | 8,253 | $829K |
| 80047 | 8,257 | 7,227 | $792K | |
| 96402 | 2,538 | 2,302 | $727K | |
| 92551 | 8,935 | 8,813 | $694K | |
| 96367 | 5,016 | 3,725 | $688K | |
| 71046 | Radiologic examination, chest; 2 views | 26,435 | 24,226 | $682K |
| 82330 | 24,173 | 18,774 | $679K | |
| 72141 | 1,464 | 1,416 | $674K | |
| 83655 | 11,909 | 11,663 | $673K | |
| J0475 | Injection, baclofen, 10 mg | 1,224 | 1,112 | $663K |
| 87210 | 5,422 | 5,251 | $656K | |
| 92579 | 4,756 | 4,539 | $655K | |
| 99284 | Emergency department visit for the evaluation and management, high severity | 40,067 | 36,101 | $643K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 1,889 | 1,836 | $640K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 35,094 | 33,418 | $621K |
| 59025 | Fetal non-stress test | 9,742 | 6,503 | $619K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 8,125 | 7,681 | $615K |
| 83021 | 17,114 | 13,857 | $611K | |
| 87077 | 20,607 | 17,679 | $601K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 701 | 666 | $568K |
| 82962 | 22,661 | 18,803 | $556K | |
| 31231 | 2,475 | 2,339 | $538K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 10,437 | 10,140 | $538K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 8,750 | 8,568 | $527K |
| 93296 | 5,409 | 5,177 | $524K | |
| 74018 | 7,935 | 7,459 | $522K | |
| 92523 | 4,060 | 3,856 | $516K | |
| 71250 | 4,013 | 3,785 | $498K | |
| 31575 | 1,498 | 1,413 | $494K | |
| 72197 | 1,054 | 1,011 | $494K | |
| 80061 | Lipid panel | 27,504 | 26,232 | $493K |
| 16020 | 1,022 | 734 | $481K | |
| 82728 | 33,488 | 30,732 | $474K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 11,179 | 6,530 | $466K |
| 81003 | 11,196 | 10,842 | $464K | |
| 74183 | 1,909 | 1,826 | $463K | |
| 88304 | 3,560 | 3,451 | $460K | |
| 92587 | 3,056 | 2,968 | $450K | |
| 95700 | 777 | 752 | $438K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 14,804 | 9,667 | $437K |
| 99201 | 6,256 | 6,069 | $432K | |
| 96401 | 1,534 | 977 | $429K | |
| 94060 | 1,765 | 1,732 | $428K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 9,219 | 8,989 | $427K |
| 82785 | 3,846 | 3,705 | $425K | |
| 96361 | Intravenous infusion, hydration; each additional hour | 13,879 | 7,971 | $422K |
| 86828 | 4,900 | 3,972 | $422K | |
| 80069 | 4,730 | 4,033 | $422K | |
| 81229 | 1,073 | 1,015 | $399K | |
| 95816 | 1,899 | 1,831 | $391K | |
| 74230 | 2,487 | 2,338 | $384K | |
| 87507 | 1,365 | 1,297 | $373K | |
| 82565 | 4,851 | 4,569 | $360K | |
| 92604 | 1,371 | 1,264 | $356K | |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 1,323 | 900 | $346K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 10,590 | 6,517 | $339K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 2,358 | 2,268 | $332K |
| 92526 | 5,893 | 3,456 | $331K | |
| 84439 | 23,844 | 22,392 | $329K | |
| 82570 | 26,150 | 23,039 | $319K | |
| 76830 | Ultrasound, transvaginal | 3,570 | 3,388 | $314K |
| 96523 | 1,209 | 837 | $313K | |
| 80050 | General health panel | 1,948 | 1,855 | $309K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 18,114 | 17,454 | $306K |
| 73630 | 4,497 | 3,997 | $304K | |
| 76825 | 1,899 | 1,824 | $300K | |
| 11900 | 1,333 | 1,245 | $290K | |
| D0150 | Comprehensive oral evaluation - new or established patient | 944 | 717 | $285K |
| 77336 | 2,358 | 1,211 | $283K | |
| 31579 | 422 | 403 | $282K | |
| 70450 | Computed tomography, head or brain; without contrast material | 9,284 | 8,434 | $276K |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | 978 | 847 | $275K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 2,183 | 2,151 | $275K |
| 85027 | 82,188 | 64,877 | $267K | |
| 81001 | 58,929 | 50,502 | $265K | |
| 17110 | 784 | 763 | $264K | |
| 73070 | 1,960 | 1,783 | $261K | |
| 86900 | 39,091 | 31,167 | $258K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 289 | 196 | $255K |
| 77334 | 1,206 | 875 | $252K | |
| 67028 | Intravitreal injection of a pharmacologic agent | 733 | 663 | $252K |
| 11981 | 293 | 284 | $249K | |
| 97542 | 2,863 | 2,686 | $244K | |
| 92134 | 5,475 | 5,176 | $244K | |
| 95811 | 682 | 663 | $243K | |
| 92555 | 1,475 | 1,407 | $239K | |
| 85018 | 9,217 | 8,568 | $231K | |
| 72156 | 1,530 | 1,465 | $230K | |
| 81511 | 484 | 452 | $227K | |
| 87205 | 7,272 | 6,406 | $225K | |
| 77062 | 1,273 | 1,249 | $222K | |
| J2704 | Injection, propofol, 10 mg | 69,179 | 41,119 | $218K |
| 93971 | 1,835 | 1,715 | $215K | |
| G0378 | Hospital observation service, per hour | 39,574 | 18,849 | $215K |
| 73130 | 2,902 | 2,596 | $214K | |
| 72082 | 2,199 | 2,103 | $214K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 4,355 | 3,919 | $212K |
| 92585 | 558 | 526 | $212K | |
| 92610 | 3,145 | 2,930 | $208K | |
| 82784 | 14,938 | 10,336 | $205K | |
| 58300 | 365 | 358 | $204K | |
| 96376 | 21,644 | 9,757 | $202K | |
| 92582 | 2,174 | 2,074 | $202K | |
| 71045 | Radiologic examination, chest; single view | 22,214 | 18,692 | $202K |
| 0002A | 4,047 | 4,001 | $197K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 1,250 | 1,209 | $193K |
| 82105 | 7,950 | 7,546 | $193K | |
| 85610 | 33,757 | 26,963 | $188K | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 3,930 | 3,842 | $184K |
| 73610 | 3,320 | 3,037 | $178K | |
| 0001A | 3,864 | 3,827 | $177K | |
| 88720 | 1,519 | 1,244 | $175K | |
| 92133 | 3,727 | 3,623 | $175K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 6,765 | 5,525 | $172K |
| 73521 | 2,825 | 2,689 | $171K | |
| 84702 | 7,069 | 5,692 | $169K | |
| 86038 | 4,781 | 4,629 | $169K | |
| 64642 | 1,602 | 1,488 | $169K | |
| 87486 | 1,753 | 1,493 | $166K | |
| 82247 | 4,497 | 3,180 | $160K | |
| 73090 | 2,402 | 2,124 | $158K | |
| 93922 | 1,166 | 1,097 | $155K | |
| 88342 | 3,763 | 3,395 | $155K | |
| 67311 | 621 | 607 | $153K | |
| 76536 | 1,919 | 1,858 | $153K | |
| 73590 | 2,808 | 2,482 | $149K | |
| 95800 | 746 | 702 | $148K | |
| 80197 | 24,765 | 14,872 | $148K | |
| 86762 | 9,003 | 8,555 | $148K | |
| 76885 | 945 | 919 | $148K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 46,483 | 38,177 | $147K |
| 97802 | 3,907 | 3,714 | $145K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 1,519 | 1,495 | $143K |
| 88307 | 5,124 | 4,346 | $142K | |
| 93225 | 2,203 | 2,100 | $141K | |
| 73560 | 3,806 | 3,325 | $141K | |
| 86832 | 6,033 | 5,301 | $140K | |
| 72158 | 1,259 | 1,194 | $140K | |
| 87102 | 3,297 | 3,016 | $135K | |
| 85007 | 20,863 | 15,136 | $134K | |
| 77300 | 299 | 271 | $133K | |
| Q9958 | High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml | 994 | 804 | $132K |
| 77295 | 141 | 109 | $130K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2,434 | 2,252 | $129K |
| 89051 | 3,074 | 2,517 | $129K | |
| 86480 | 5,106 | 4,763 | $128K | |
| 86359 | 5,576 | 5,217 | $128K | |
| 77386 | 1,453 | 117 | $128K | |
| 73110 | 2,039 | 1,840 | $128K | |
| 73030 | 2,868 | 2,569 | $127K | |
| 70486 | 1,690 | 1,604 | $124K | |
| 69210 | 703 | 669 | $123K | |
| G0270 | Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes | 5,323 | 4,751 | $123K |
| 97162 | 6,468 | 6,025 | $122K | |
| 93308 | 1,636 | 1,458 | $120K | |
| 43762 | 2,307 | 2,136 | $118K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 4,518 | 4,396 | $117K |
| 76801 | 2,649 | 2,430 | $114K | |
| 73140 | 867 | 817 | $114K | |
| 76642 | 3,112 | 2,594 | $113K | |
| 86704 | 4,178 | 3,775 | $113K | |
| 86803 | 20,149 | 19,178 | $113K | |
| 99215 | Prolong outpt/office vis | 10,612 | 10,006 | $111K |
| 92524 | 1,099 | 1,047 | $111K | |
| 82670 | 1,946 | 1,882 | $111K | |
| 83516 | 4,382 | 3,541 | $106K | |
| 64615 | 1,612 | 1,554 | $106K | |
| 93970 | 733 | 680 | $105K | |
| 82607 | 10,547 | 10,149 | $101K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 13,468 | 5,736 | $100K |
| 94664 | 5,523 | 5,189 | $100K | |
| 80076 | 4,981 | 4,667 | $99K | |
| 82627 | 913 | 898 | $97K | |
| 77290 | 86 | 68 | $95K | |
| 97116 | 4,099 | 1,978 | $95K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 291 | 281 | $93K |
| 97161 | 4,681 | 4,526 | $93K | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 1,314 | 705 | $93K |
| 73552 | 1,941 | 1,731 | $92K | |
| 11982 | 385 | 355 | $92K | |
| 86140 | 17,505 | 15,887 | $92K | |
| 93304 | 1,169 | 997 | $92K | |
| 82043 | 7,524 | 7,285 | $90K | |
| 83001 | 3,151 | 3,081 | $89K | |
| 82040 | 5,041 | 4,861 | $89K | |
| 84443 | Thyroid stimulating hormone (TSH) | 35,078 | 32,672 | $88K |
| 97535 | Self-care/home management training, each 15 minutes | 4,583 | 2,732 | $88K |
| 76937 | 3,196 | 2,673 | $88K | |
| 88341 | 2,105 | 1,430 | $88K | |
| 74019 | 1,471 | 1,411 | $87K | |
| 10060 | 528 | 504 | $87K | |
| 90686 | 16,097 | 15,734 | $85K | |
| 86003 | 4,927 | 3,158 | $85K | |
| 73562 | 1,568 | 1,341 | $84K | |
| 92602 | 249 | 200 | $83K | |
| 77080 | 779 | 744 | $82K | |
| 83519 | 1,390 | 1,278 | $81K | |
| 72100 | 2,089 | 2,011 | $80K | |
| P9016 | Red blood cells, leukocytes reduced, each unit | 6,400 | 5,273 | $80K |
| 73502 | 2,186 | 2,055 | $78K | |
| 95886 | 631 | 619 | $77K | |
| 83520 | 2,245 | 2,075 | $77K | |
| 69209 | 530 | 515 | $77K | |
| 92025 | 1,044 | 1,002 | $76K | |
| 92083 | 3,583 | 3,467 | $75K | |
| 94776 | 310 | 285 | $74K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 3,656 | 3,405 | $73K |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | 1,269 | 1,212 | $72K |
| 93017 | 1,196 | 1,153 | $70K | |
| 84484 | 26,365 | 17,198 | $69K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 31,202 | 29,930 | $69K |
| 96368 | 1,290 | 1,002 | $69K | |
| 87529 | 2,572 | 1,621 | $68K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 2,548 | 1,024 | $68K |
| 77072 | 1,518 | 1,477 | $67K | |
| 74220 | 727 | 710 | $67K | |
| 94618 | 2,574 | 2,438 | $67K | |
| 76870 | 645 | 612 | $66K | |
| 80074 | 1,348 | 1,248 | $65K | |
| 82310 | 2,075 | 1,852 | $65K | |
| 87075 | 2,370 | 2,025 | $64K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 64,349 | 51,598 | $64K |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 670 | 620 | $64K |
| 87807 | 772 | 756 | $63K | |
| 0064U | 206 | 189 | $61K | |
| 95885 | 417 | 412 | $59K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 289 | 286 | $59K |
| 0065U | 249 | 234 | $59K | |
| 0099U | 920 | 869 | $58K | |
| 0003A | 1,683 | 1,632 | $58K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 15,421 | 11,423 | $56K |
| 83880 | 12,981 | 11,051 | $56K | |
| 94621 | 299 | 283 | $56K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 2,315 | 2,210 | $56K |
| 87015 | 952 | 841 | $55K | |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 954 | 941 | $54K |
| P9612 | Catheterization for collection of specimen, single patient, all places of service | 1,240 | 1,165 | $54K |
| 93320 | 11,357 | 9,928 | $53K | |
| 72040 | 1,171 | 1,140 | $53K | |
| 97165 | 2,138 | 1,996 | $53K | |
| D1120 | Prophylaxis - child | 777 | 613 | $53K |
| C1729 | Catheter, drainage | 2,353 | 1,743 | $52K |
| 90715 | 7,622 | 7,440 | $51K | |
| 36593 | 1,299 | 882 | $50K | |
| 92552 | 303 | 290 | $49K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 7,499 | 7,122 | $49K |
| 92250 | 3,101 | 2,968 | $48K | |
| 49083 | 444 | 240 | $47K | |
| 86146 | 1,550 | 1,031 | $47K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | 1,771 | 1,719 | $46K |
| 77066 | Tomosynthesis, mammo | 1,750 | 1,717 | $45K |
| 76942 | 1,159 | 1,078 | $45K | |
| 80164 | 2,395 | 2,183 | $44K | |
| 82550 | 5,135 | 4,431 | $44K | |
| 78306 | 264 | 251 | $44K | |
| 93975 | 3,306 | 3,091 | $44K | |
| 20610 | 647 | 620 | $44K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 2,351 | 2,321 | $43K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 10,685 | 10,061 | $43K |
| 77061 | 302 | 294 | $43K | |
| J1170 | Injection, hydromorphone, up to 4 mg | 37,105 | 19,131 | $43K |
| 84305 | 2,117 | 2,050 | $43K | |
| C1769 | Guide wire | 10,879 | 9,397 | $43K |
| Q9950 | Injection, sulfur hexafluoride lipid microspheres, per ml | 287 | 142 | $42K |
| 97803 | 3,195 | 2,906 | $41K | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 4,673 | 3,836 | $40K |
| 80177 | 1,495 | 1,397 | $39K | |
| 86592 | 1,161 | 1,051 | $39K | |
| 87040 | 8,342 | 5,512 | $38K | |
| 86902 | 7,654 | 4,797 | $38K | |
| 73060 | 771 | 708 | $38K | |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 940 | 895 | $36K |
| 97166 | 2,867 | 2,619 | $36K | |
| 88184 | 2,216 | 1,666 | $36K | |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | 6,578 | 5,741 | $36K |
| 86706 | 5,530 | 5,055 | $36K | |
| 88172 | 1,266 | 1,107 | $36K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 624 | 598 | $36K |
| 80320 | 3,471 | 3,057 | $36K | |
| 93880 | 268 | 239 | $36K | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1,474 | 1,426 | $35K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 334 | 323 | $35K |
| 86225 | 6,076 | 5,804 | $35K | |
| 93299 | 532 | 510 | $35K | |
| 76512 | 417 | 374 | $35K | |
| 0072A | 872 | 852 | $34K | |
| 87340 | 18,035 | 16,870 | $34K | |
| 83735 | 64,678 | 41,201 | $34K | |
| 92136 | 646 | 623 | $33K | |
| 43235 | 1,243 | 1,212 | $32K | |
| 76882 | 538 | 506 | $32K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 1,694 | 1,573 | $32K |
| 72146 | 157 | 149 | $31K | |
| 84146 | 2,341 | 2,284 | $31K | |
| 82390 | 4,697 | 4,631 | $31K | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 5,741 | 2,524 | $30K |
| 87536 | 4,645 | 4,387 | $30K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 43,673 | 42,090 | $30K |
| 97750 | 731 | 663 | $30K | |
| 82803 | 30,575 | 22,960 | $30K | |
| 90670 | 7,129 | 7,042 | $29K | |
| Q2036 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) | 7,425 | 7,321 | $29K |
| 86695 | 1,206 | 1,051 | $28K | |
| 73100 | 318 | 287 | $28K | |
| 86355 | 2,503 | 2,249 | $28K | |
| 87522 | Neg quan hep c or qual rna | 2,846 | 2,647 | $28K |
| 72157 | 838 | 792 | $27K | |
| 76818 | 229 | 198 | $27K | |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | 3,965 | 2,815 | $27K |
| 72170 | 929 | 878 | $27K | |
| 17250 | 69 | 62 | $27K | |
| J1644 | Injection, heparin sodium, per 1000 units | 15,253 | 8,648 | $27K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 612 | 549 | $26K |
| 94726 | 2,170 | 2,061 | $26K | |
| C9113 | Injection, pantoprazole sodium, per vial | 1,910 | 681 | $26K |
| 96409 | 2,798 | 1,795 | $26K | |
| 93321 | 2,706 | 2,350 | $26K | |
| 86644 | 2,859 | 2,485 | $26K | |
| 87101 | 322 | 294 | $26K | |
| 54161 | 607 | 605 | $26K | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 31,354 | 12,729 | $26K |
| 0399T | 789 | 613 | $26K | |
| 86769 | 843 | 803 | $25K | |
| 88302 | 123 | 116 | $25K | |
| 76376 | 185 | 181 | $25K | |
| 12011 | 210 | 205 | $25K | |
| 82103 | 697 | 646 | $24K | |
| 78451 | 98 | 95 | $24K | |
| 36416 | 19,253 | 17,697 | $23K | |
| 95951 | 204 | 149 | $23K | |
| 82085 | 594 | 564 | $23K | |
| 83993 | 919 | 876 | $23K | |
| 84100 | 48,940 | 31,246 | $23K | |
| 97163 | 2,588 | 2,443 | $23K | |
| A9609 | Fludeoxyglucose f18 up to 15 millicuries | 67 | 65 | $23K |
| 0071A | 588 | 583 | $22K | |
| 82533 | 1,780 | 1,631 | $22K | |
| 87497 | 9,550 | 6,288 | $22K | |
| 86317 | 5,384 | 3,127 | $22K | |
| 93351 | 561 | 504 | $22K | |
| 77065 | Tomosynthesis, mammo | 869 | 851 | $22K |
| 70480 | 105 | 102 | $21K | |
| 83615 | 18,494 | 14,203 | $21K | |
| 74455 | 468 | 462 | $21K | |
| 95819 | 143 | 138 | $21K | |
| 90633 | 5,555 | 5,466 | $21K | |
| 31526 | 339 | 297 | $21K | |
| 94681 | 76 | 71 | $21K | |
| 82378 | 1,189 | 1,104 | $21K | |
| 86481 | 1,087 | 1,025 | $21K | |
| 43760 | 358 | 324 | $21K | |
| 76000 | 999 | 967 | $20K | |
| D2930 | Prefabricated stainless steel crown - primary tooth | 397 | 322 | $20K |
| 76820 | 4,293 | 2,255 | $20K | |
| 20680 | 89 | 88 | $20K | |
| 12001 | 102 | 99 | $20K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 23,855 | 20,615 | $20K |
| 86696 | 1,437 | 1,273 | $19K | |
| 95708 | 109 | 50 | $19K | |
| 93270 | 100 | 95 | $19K | |
| 93298 | 417 | 407 | $19K | |
| 85014 | 28,684 | 23,513 | $18K | |
| 84402 | 1,390 | 1,353 | $18K | |
| 92651 | 176 | 173 | $18K | |
| 74240 | 127 | 123 | $18K | |
| 76813 | 264 | 247 | $18K | |
| 83540 | 22,025 | 20,670 | $18K | |
| 70491 | 1,710 | 1,618 | $17K | |
| 92611 | 2,613 | 2,451 | $17K | |
| 42830 | 89 | 87 | $17K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 10,314 | 7,795 | $16K |
| 84155 | 5,395 | 5,149 | $16K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 290 | 243 | $16K |
| 0097U | 568 | 534 | $16K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 29,319 | 26,625 | $16K |
| 85730 | 14,652 | 12,547 | $16K | |
| 86200 | 1,896 | 1,865 | $15K | |
| 84436 | 683 | 669 | $15K | |
| 73080 | 190 | 177 | $15K | |
| 90651 | 5,250 | 5,178 | $15K | |
| 0053A | 890 | 866 | $15K | |
| 88314 | 989 | 756 | $15K | |
| 88112 | 1,451 | 1,329 | $14K | |
| 72081 | 151 | 143 | $14K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 51,502 | 49,428 | $14K |
| J3475 | Injection, magnesium sulfate, per 500 mg | 5,589 | 3,627 | $14K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 7,677 | 5,903 | $14K |
| C1751 | Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) | 2,287 | 1,814 | $14K |
| 84481 | 2,385 | 2,223 | $13K | |
| 41899 | Unlisted procedure, dentoalveolar structures | 572 | 518 | $13K |
| J2550 | Injection, promethazine hcl, up to 50 mg | 4,879 | 3,579 | $13K |
| 77001 | 919 | 857 | $13K | |
| 82150 | 1,909 | 1,391 | $13K | |
| 92586 | 60 | 56 | $13K | |
| 80175 | 630 | 592 | $13K | |
| 54150 | 52 | 52 | $12K | |
| 82024 | 211 | 200 | $12K | |
| 70543 | 73 | 73 | $12K | |
| 95953 | 32 | 13 | $12K | |
| 82270 | 146 | 136 | $12K | |
| 90696 | 1,879 | 1,853 | $12K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 44,800 | 39,740 | $12K |
| 83921 | 605 | 555 | $12K | |
| 84145 | 1,472 | 1,328 | $12K | |
| 86235 | 4,150 | 2,701 | $12K | |
| P9038 | Red blood cells, irradiated, each unit | 1,312 | 986 | $12K |
| J0690 | Injection, cefazolin sodium, 500 mg | 21,193 | 17,626 | $12K |
| L0172 | Cervical, collar, semi-rigid thermoplastic foam, two-piece, prefabricated, off-the-shelf | 196 | 185 | $11K |
| 82525 | 505 | 479 | $11K | |
| 82610 | 7,335 | 6,405 | $11K | |
| 85396 | 141 | 135 | $11K | |
| 82652 | 476 | 449 | $11K | |
| C1725 | Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) | 2,436 | 2,088 | $11K |
| P9040 | Red blood cells, leukocytes reduced, irradiated, each unit | 645 | 479 | $11K |
| 72070 | 283 | 274 | $10K | |
| 83498 | 940 | 922 | $10K | |
| 87631 | 887 | 818 | $10K | |
| 58301 | 66 | 64 | $10K | |
| J3480 | Injection, potassium chloride, per 2 meq | 2,535 | 1,409 | $10K |
| 85379 | 3,158 | 2,896 | $10K | |
| 84134 | 4,495 | 4,239 | $10K | |
| 84403 | 4,282 | 4,031 | $10K | |
| 87186 | 12,029 | 10,987 | $10K | |
| 70250 | 82 | 73 | $10K | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 3,057 | 2,728 | $10K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 31,673 | 27,168 | $10K |
| 97032 | 108 | 52 | $9K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 12,350 | 8,308 | $9K |
| 86364 | 2,554 | 2,118 | $9K | |
| 84270 | 479 | 467 | $9K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 48,709 | 47,487 | $9K |
| 85652 | 17,128 | 16,056 | $9K | |
| 73120 | 540 | 337 | $9K | |
| 83690 | 17,144 | 14,431 | $9K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 871 | 841 | $9K |
| 86645 | 234 | 219 | $9K | |
| 90677 | 2,353 | 2,307 | $9K | |
| 77073 | 117 | 114 | $9K | |
| 84156 | 20,515 | 17,454 | $9K | |
| 84144 | 241 | 226 | $9K | |
| 73564 | 208 | 152 | $8K | |
| 92556 | 178 | 166 | $8K | |
| 84446 | 1,201 | 1,171 | $8K | |
| 78264 | 27 | 26 | $8K | |
| 84630 | 6,097 | 5,926 | $8K | |
| 88230 | 483 | 460 | $8K | |
| 83970 | 10,092 | 9,347 | $8K | |
| 86787 | 4,621 | 4,219 | $8K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 1,027 | 858 | $8K |
| 81513 | 91 | 85 | $8K | |
| 93325 | 15,874 | 13,939 | $8K | |
| 82077 | 854 | 772 | $8K | |
| 84681 | 768 | 721 | $7K | |
| 82657 | 70 | 66 | $7K | |
| 88346 | 2,089 | 1,629 | $7K | |
| L3908 | Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf | 74 | 69 | $7K |
| 73620 | 518 | 353 | $7K | |
| 86160 | 6,255 | 4,092 | $7K | |
| 88185 | 2,709 | 1,477 | $7K | |
| 82746 | 9,060 | 8,698 | $7K | |
| 87150 | 69 | 64 | $7K | |
| 86705 | 632 | 567 | $7K | |
| 75809 | 97 | 87 | $7K | |
| 92652 | 120 | 117 | $7K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 1,455 | 1,390 | $7K |
| 31622 | 294 | 263 | $6K | |
| 82010 | 1,318 | 1,179 | $6K | |
| 86255 | 176 | 153 | $6K | |
| 76377 | 131 | 100 | $6K | |
| 99205 | Prolong outpt/office vis | 269 | 264 | $6K |
| D1351 | Sealant - per tooth | 303 | 241 | $6K |
| 97760 | 31 | 27 | $6K | |
| 97597 | 416 | 287 | $6K | |
| 87799 | 11,619 | 7,556 | $6K | |
| 82248 | 17,899 | 15,675 | $6K | |
| 92609 | 892 | 387 | $6K | |
| 75574 | 942 | 897 | $6K | |
| 77370 | 36 | 24 | $6K | |
| C1830 | Powered bone marrow biopsy needle | 13 | 12 | $6K |
| 0052A | 246 | 239 | $6K | |
| 85045 | 24,846 | 18,679 | $6K | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 1,518 | 762 | $6K |
| 85384 | 3,127 | 2,053 | $6K | |
| 73522 | 129 | 129 | $6K | |
| 86880 | 98 | 81 | $6K | |
| 70496 | 764 | 724 | $6K | |
| D0220 | Intraoral - periapical first radiographic image | 309 | 265 | $6K |
| 84165 | 3,014 | 2,743 | $6K | |
| 76857 | 1,145 | 1,117 | $6K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1,326 | 1,234 | $6K |
| 83002 | 2,663 | 2,582 | $6K | |
| 75561 | 68 | 67 | $6K | |
| 36430 | 6,990 | 4,961 | $6K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 2,203 | 1,863 | $5K |
| 90620 | 1,637 | 1,602 | $5K | |
| 80195 | 667 | 458 | $5K | |
| D0240 | 51 | 44 | $5K | |
| 84550 | 6,809 | 5,188 | $5K | |
| 86663 | 371 | 364 | $5K | |
| 88173 | 1,545 | 1,345 | $5K | |
| 95713 | 94 | 93 | $5K | |
| 64643 | 1,050 | 947 | $5K | |
| 84207 | 3,115 | 3,080 | $5K | |
| D7140 | Extraction, erupted tooth or exposed root | 585 | 450 | $5K |
| 90700 | 1,969 | 1,954 | $5K | |
| 87081 | 481 | 462 | $5K | |
| 87206 | 1,825 | 1,534 | $5K | |
| 86304 | 1,506 | 1,228 | $5K | |
| 76641 | 108 | 103 | $5K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 127 | 126 | $5K |
| 49591 | 26 | 26 | $5K | |
| 82945 | 2,052 | 1,705 | $5K | |
| 93750 | 1,417 | 1,060 | $5K | |
| 90935 | Hemodialysis procedure with single evaluation by a physician | 1,989 | 814 | $5K |
| 82977 | 6,133 | 5,213 | $5K | |
| 99195 | 2,368 | 1,928 | $5K | |
| D0272 | Bitewings - two radiographic images | 250 | 217 | $5K |
| 51784 | 404 | 379 | $5K | |
| 93886 | 459 | 450 | $5K | |
| 84480 | 1,109 | 1,029 | $5K | |
| 84295 | 14,326 | 11,495 | $4K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 33 | 32 | $4K |
| 80183 | 383 | 373 | $4K | |
| 81370 | 226 | 200 | $4K | |
| 36226 | 121 | 114 | $4K | |
| 90732 | 1,145 | 1,089 | $4K | |
| 85613 | 693 | 630 | $4K | |
| 90656 | 1,321 | 1,286 | $4K | |
| 87641 | 1,544 | 1,439 | $4K | |
| 0012A | 70 | 69 | $4K | |
| 91308 | 144 | 135 | $4K | |
| 84703 | 535 | 513 | $4K | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 4,246 | 3,682 | $4K |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 1,664 | 1,542 | $4K |
| 80158 | 405 | 176 | $4K | |
| 83525 | 872 | 827 | $4K | |
| 81479 | Unlisted molecular pathology procedure | 29 | 26 | $4K |
| 85240 | 395 | 368 | $4K | |
| 87640 | 1,048 | 991 | $4K | |
| J1630 | Injection, haloperidol, up to 5 mg | 3,155 | 2,783 | $4K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 1,115 | 926 | $4K |
| 92550 | 42 | 41 | $4K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 68 | 68 | $4K |
| 82950 | 2,900 | 2,813 | $4K | |
| 81243 | 160 | 149 | $4K | |
| 19318 | 61 | 61 | $4K | |
| 62369 | 611 | 572 | $4K | |
| 64644 | 100 | 90 | $4K | |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 432 | 391 | $4K |
| J3370 | Injection, vancomycin hcl, 500 mg | 2,152 | 1,582 | $4K |
| 92597 | 106 | 96 | $4K | |
| 49465 | 29 | 27 | $4K | |
| 84425 | 4,717 | 4,661 | $3K | |
| J1940 | Injection, furosemide, up to 20 mg | 2,524 | 1,792 | $3K |
| 74178 | 441 | 424 | $3K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 11,411 | 11,063 | $3K |
| 87338 | 212 | 209 | $3K | |
| C1758 | Catheter, ureteral | 1,746 | 1,649 | $3K |
| 84157 | 2,169 | 1,795 | $3K | |
| 73000 | 39 | 36 | $3K | |
| 84132 | 14,943 | 11,950 | $3K | |
| 82140 | 238 | 224 | $3K | |
| 90734 | 4,679 | 4,604 | $3K | |
| 87481 | 100 | 95 | $3K | |
| 82951 | 447 | 431 | $3K | |
| 54640 | 13 | 13 | $3K | |
| 86665 | 2,707 | 2,365 | $3K | |
| 83605 | 25,227 | 20,001 | $3K | |
| 86923 | 10,070 | 6,104 | $3K | |
| 84432 | 83 | 78 | $3K | |
| J2060 | Injection, lorazepam, 2 mg | 2,534 | 2,043 | $3K |
| 92511 | 30 | 29 | $3K | |
| 81231 | 15 | 13 | $3K | |
| B4088 | Gastrostomy/jejunostomy tube, low-profile, any material, any type, each | 13 | 13 | $3K |
| 97014 | 27 | 12 | $3K | |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 3,221 | 2,964 | $3K |
| 90710 | 2,575 | 2,540 | $3K | |
| 11100 | 165 | 160 | $3K | |
| 73600 | 62 | 52 | $3K | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 5,246 | 4,923 | $3K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 5,435 | 4,996 | $3K |
| 11102 | 195 | 187 | $3K | |
| J1610 | Injection, glucagon hydrochloride, per 1 mg | 29 | 25 | $2K |
| 83521 | 1,537 | 699 | $2K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 2,319 | 2,138 | $2K |
| 70544 | 12 | 12 | $2K | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 7,907 | 6,737 | $2K |
| 51600 | 541 | 523 | $2K | |
| 86147 | 1,564 | 1,049 | $2K | |
| J0612 | Injection, calcium gluconate, not otherwise specified, 10 mg | 365 | 244 | $2K |
| 0124A | 508 | 498 | $2K | |
| 83020 | 60 | 56 | $2K | |
| 84300 | 556 | 515 | $2K | |
| 94644 | 675 | 594 | $2K | |
| 74181 | 12 | 12 | $2K | |
| 96411 | 1,910 | 1,286 | $2K | |
| J1790 | Injection, droperidol, up to 5 mg | 1,373 | 1,154 | $2K |
| 96118 | 42 | 40 | $2K | |
| 51798 | 373 | 346 | $2K | |
| 0051A | 109 | 108 | $2K | |
| 51741 | 73 | 67 | $2K | |
| 86431 | 1,844 | 1,804 | $2K | |
| 36600 | 195 | 167 | $2K | |
| 51701 | 668 | 613 | $2K | |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 608 | 574 | $2K |
| 76506 | 15 | 12 | $2K | |
| 86376 | 1,748 | 1,682 | $2K | |
| 84445 | 163 | 160 | $2K | |
| G0379 | Direct admission of patient for hospital observation care | 263 | 239 | $2K |
| 92626 | 43 | 41 | $2K | |
| 82272 | 45 | 42 | $2K | |
| 93280 | 12 | 12 | $2K | |
| 84153 | 812 | 698 | $2K | |
| 97035 | 43 | 26 | $2K | |
| 82157 | 50 | 48 | $2K | |
| 96138 | 103 | 95 | $2K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 3,337 | 2,592 | $2K |
| 83883 | 1,707 | 1,115 | $2K | |
| 36561 | 53 | 52 | $2K | |
| 88313 | 2,508 | 1,897 | $2K | |
| 80143 | 114 | 103 | $2K | |
| 80329 | 249 | 229 | $2K | |
| 87517 | 540 | 492 | $2K | |
| 82164 | 52 | 49 | $2K | |
| 52310 | 46 | 41 | $2K | |
| 86870 | 594 | 369 | $2K | |
| 76821 | 2,448 | 1,318 | $2K | |
| L4386 | Walking boot, non-pneumatic, with or without joints, with or without interface material, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise | 14 | 14 | $2K |
| 86162 | 119 | 113 | $2K | |
| 86833 | 5,847 | 5,142 | $2K | |
| 86357 | 1,816 | 1,644 | $2K | |
| 90678 | 59 | 57 | $2K | |
| 86258 | 460 | 233 | $1K | |
| 88360 | 52 | 47 | $1K | |
| 80321 | 434 | 391 | $1K | |
| 36591 | 12,997 | 7,760 | $1K | |
| 85046 | 3,474 | 2,527 | $1K | |
| 85397 | 25 | 24 | $1K | |
| 97164 | 57 | 54 | $1K | |
| G0008 | Administration of influenza virus vaccine | 6,559 | 6,429 | $1K |
| 74022 | 266 | 252 | $1K | |
| 80179 | 75 | 70 | $1K | |
| 94770 | 15 | 12 | $1K | |
| 80323 | 78 | 67 | $1K | |
| 84450 | 1,177 | 1,105 | $1K | |
| 50435 | 59 | 51 | $1K | |
| 90716 | 1,732 | 1,693 | $1K | |
| 90707 | 1,674 | 1,651 | $1K | |
| 11721 | 15 | 15 | $1K | |
| 91307 | 55 | 55 | $1K | |
| J2785 | Injection, regadenoson, 0.1 mg | 310 | 292 | $1K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 852 | 787 | $1K |
| M0244 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency | 31 | 30 | $1K |
| 94729 | 5,739 | 5,438 | $1K | |
| 85347 | 2,792 | 1,956 | $1K | |
| 0154A | 91 | 91 | $1K | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 160 | 143 | $1K |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | 163 | 138 | $1K |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 653 | 563 | $1K |
| 0082A | 112 | 110 | $1K | |
| 99407 | 35 | 28 | $987.52 | |
| J3372 | Injection, vancomycin hcl (xellia), not therapeutically equivalent to j3370, 500 mg | 418 | 267 | $976.88 |
| 86735 | 203 | 193 | $967.83 | |
| 95911 | 27 | 25 | $966.22 | |
| M0222 | Intravenous injection, bebtelovimab, includes injection and post administration monitoring | 20 | 19 | $963.83 |
| 86777 | 1,053 | 871 | $945.76 | |
| 86580 | 111 | 99 | $935.41 | |
| 84460 | 2,659 | 2,529 | $933.83 | |
| 95874 | 1,307 | 1,214 | $927.80 | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | 190 | 132 | $903.89 |
| 76827 | 976 | 929 | $901.11 | |
| J1815 | Injection, insulin, per 5 units | 145 | 72 | $876.32 |
| J1756 | Injection, iron sucrose, 1 mg | 2,468 | 1,467 | $869.27 |
| 92504 | 904 | 870 | $863.16 | |
| 70498 | 1,103 | 1,047 | $844.30 | |
| 77412 | 300 | 39 | $837.42 | |
| 90660 | 85 | 84 | $832.02 | |
| A4210 | Needle-free injection device, each | 82 | 81 | $818.73 |
| 82435 | 1,001 | 910 | $811.05 | |
| 86708 | 967 | 851 | $779.17 | |
| 84590 | 1,218 | 1,188 | $776.86 | |
| 90685 | 306 | 301 | $744.68 | |
| 78803 | 12 | 12 | $730.59 | |
| 0011A | 12 | 12 | $728.79 | |
| 84478 | 390 | 255 | $698.02 | |
| 86341 | 54 | 49 | $695.95 | |
| 93356 | 3,157 | 2,749 | $681.67 | |
| 90723 | 6,265 | 6,213 | $659.37 | |
| 84075 | 753 | 685 | $654.28 | |
| 92522 | 12 | 12 | $637.15 | |
| 90744 | 287 | 260 | $635.08 | |
| 97022 | 27 | 12 | $603.87 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 16,903 | 16,628 | $580.00 |
| 72131 | 12 | 12 | $550.67 | |
| 62270 | 307 | 260 | $537.38 | |
| 90694 | 432 | 414 | $532.08 | |
| 90661 | 273 | 272 | $519.24 | |
| 82379 | 168 | 161 | $498.88 | |
| J9370 | Vincristine sulfate, 1 mg | 2,088 | 1,389 | $493.29 |
| 87184 | 800 | 727 | $490.38 | |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 435 | 317 | $475.45 |
| 99173 | 9,243 | 9,120 | $460.22 | |
| 81374 | 12 | 12 | $454.87 | |
| 87177 | 15 | 14 | $433.96 | |
| 86301 | 172 | 158 | $424.42 | |
| 87625 | 317 | 311 | $402.26 | |
| 82365 | 14 | 13 | $387.30 | |
| 29065 | 25 | 25 | $377.96 | |
| 76776 | 56 | 51 | $355.35 | |
| 99152 | 5,263 | 4,833 | $337.84 | |
| 76932 | 252 | 179 | $314.60 | |
| 91320 | 112 | 108 | $311.00 | |
| 0081A | 65 | 65 | $287.00 | |
| 86039 | 2,148 | 2,078 | $285.28 | |
| 90680 | 3,262 | 3,243 | $276.77 | |
| M0247 | Intravenous infusion, sotrovimab, includes infusion and post administration monitoring | 74 | 69 | $268.50 |
| 82088 | 13 | 13 | $259.75 | |
| J0735 | Injection, clonidine hydrochloride, 1 mg | 424 | 417 | $246.19 |
| 86308 | 12 | 12 | $238.69 | |
| J0610 | Injection, calcium gluconate (fresenius kabi), per 10 ml | 1,836 | 1,159 | $231.47 |
| 83930 | 76 | 66 | $230.45 | |
| 83010 | 404 | 372 | $214.03 | |
| 85246 | 58 | 57 | $203.24 | |
| 86901 | 36,812 | 29,543 | $197.61 | |
| 86334 | 1,391 | 1,239 | $190.48 | |
| 96120 | 118 | 115 | $182.39 | |
| 80201 | 14 | 14 | $155.99 | |
| 87116 | 1,009 | 885 | $145.02 | |
| 75573 | 61 | 54 | $144.36 | |
| 96139 | 102 | 94 | $144.00 | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 1,747 | 1,624 | $140.90 |
| J0295 | Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm | 1,472 | 987 | $140.10 |
| 86825 | 17 | 12 | $135.29 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 2,133 | 1,568 | $129.94 |
| 81406 | 26 | 24 | $126.40 | |
| 86920 | 2,211 | 1,461 | $122.85 | |
| 92227 | 47 | 45 | $120.60 | |
| C1760 | Closure device, vascular (implantable/insertable) | 313 | 294 | $118.00 |
| 96146 | 77 | 74 | $103.83 | |
| 86360 | 5,548 | 5,174 | $92.70 | |
| 88108 | 617 | 516 | $91.09 | |
| 31502 | 12 | 12 | $85.09 | |
| 87088 | 1,467 | 1,389 | $81.73 | |
| 51728 | 100 | 91 | $75.19 | |
| 86008 | 202 | 187 | $69.16 | |
| 86800 | 966 | 921 | $65.91 | |
| 86141 | 34 | 25 | $64.43 | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 864 | 740 | $52.39 |
| 90655 | 82 | 79 | $46.69 | |
| 87581 | 1,752 | 1,493 | $45.24 | |
| 51797 | 94 | 87 | $40.90 | |
| 86682 | 26 | 22 | $30.89 | |
| 84244 | 27 | 27 | $27.79 | |
| 83935 | 13 | 12 | $25.33 | |
| 82239 | 12 | 12 | $23.42 | |
| 85245 | 61 | 61 | $23.28 | |
| 82373 | 27 | 27 | $23.27 | |
| 82397 | 14 | 13 | $19.31 | |
| 88312 | 1,426 | 1,210 | $19.17 | |
| 84466 | 9,110 | 8,565 | $17.45 | |
| 86765 | 242 | 232 | $16.94 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | 3,849 | 3,315 | $5.01 |
| 84166 | 90 | 80 | $0.24 | |
| 91318 | 27 | 27 | $0.02 | |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 589 | 541 | $0.00 |
| 88261 | 425 | 400 | $0.00 | |
| G8985 | Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 110 | 85 | $0.00 |
| 86922 | 833 | 547 | $0.00 | |
| 84597 | 281 | 279 | $0.00 | |
| 87107 | 123 | 119 | $0.00 | |
| Q5107 | Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg | 16 | 12 | $0.00 |
| 96417 | 2,822 | 1,866 | $0.00 | |
| 93567 | 101 | 85 | $0.00 | |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 3,337 | 2,803 | $0.00 |
| 77012 | 305 | 290 | $0.00 | |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | 118 | 96 | $0.00 |
| J1453 | Injection, fosaprepitant, 1 mg | 1,402 | 987 | $0.00 |
| 82374 | 935 | 857 | $0.00 | |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | 80 | 66 | $0.00 |
| 76981 | 477 | 455 | $0.00 | |
| 85670 | 170 | 158 | $0.00 | |
| 88237 | 295 | 234 | $0.00 | |
| 36592 | 202 | 123 | $0.00 | |
| D2929 | 66 | 50 | $0.00 | |
| 36224 | 86 | 71 | $0.00 | |
| J0744 | Injection, ciprofloxacin for intravenous infusion, 200 mg | 376 | 317 | $0.00 |
| J9271 | Injection, pembrolizumab, 1 mg | 914 | 728 | $0.00 |
| 82542 | 13 | 12 | $0.00 | |
| G8984 | Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals | 89 | 68 | $0.00 |
| 81450 | 52 | 43 | $0.00 | |
| 11104 | 24 | 24 | $0.00 | |
| 81329 | 231 | 203 | $0.00 | |
| 84520 | 967 | 887 | $0.00 | |
| J1953 | Injection, levetiracetam, 10 mg | 466 | 339 | $0.00 |
| 85300 | 16 | 13 | $0.00 | |
| 75970 | 35 | 24 | $0.00 | |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 455 | 376 | $0.00 |
| G8996 | Swallowing functional limitation, current status at therapy episode outset and at reporting intervals | 95 | 71 | $0.00 |
| J3489 | Injection, zoledronic acid, 1 mg | 14 | 12 | $0.00 |
| J9190 | Injection, fluorouracil, 500 mg | 212 | 111 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 446 | 373 | $0.00 |
| 75827 | 30 | 25 | $0.00 | |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | 53 | 45 | $0.00 |
| 80365 | 380 | 243 | $0.00 | |
| 87899 | 19 | 17 | $0.00 | |
| J0692 | Injection, cefepime hydrochloride, 500 mg | 64 | 38 | $0.00 |
| C1788 | Port, indwelling (implantable) | 134 | 126 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 201 | 148 | $0.00 |
| 90713 | 42 | 41 | $0.00 | |
| Q0244 | Injection, casirivimab and imdevimab, 1200 mg | 29 | 28 | $0.00 |
| J9260 | Injection, methotrexate sodium, 50 mg | 57 | 41 | $0.00 |
| 85049 | 142 | 92 | $0.00 | |
| 82465 | 18 | 17 | $0.00 | |
| J0897 | Injection, denosumab, 1 mg | 13 | 12 | $0.00 |
| 36005 | 47 | 45 | $0.00 | |
| 93460 | 54 | 50 | $0.00 | |
| A4315 | Insertion tray with drainage bag with indwelling catheter, foley type, two-way, all silicone | 112 | 107 | $0.00 |
| A9541 | Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries | 37 | 37 | $0.00 |
| P9045 | Infusion, albumin (human), 5%, 250 ml | 87 | 42 | $0.00 |
| C1757 | Catheter, thrombectomy/embolectomy | 46 | 40 | $0.00 |
| 85306 | 17 | 14 | $0.00 | |
| 90473 | 55 | 54 | $0.00 | |
| 36010 | 12 | 12 | $0.00 | |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 58 | 39 | $0.00 |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 45 | 24 | $0.00 |
| 87076 | 13 | 13 | $0.00 | |
| J2323 | Injection, natalizumab, 1 mg | 13 | 12 | $0.00 |
| G8997 | Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 95 | 71 | $0.00 |
| C1776 | Joint device (implantable) | 13 | 13 | $0.00 |
| 10005 | 13 | 13 | $0.00 | |
| J7511 | Lymphocyte immune globulin, antithymocyte globulin, rabbit, parenteral, 25 mg | 85 | 40 | $0.00 |
| 87209 | 15 | 14 | $0.00 | |
| 54360 | 12 | 12 | $0.00 | |
| J9035 | Injection, bevacizumab, 10 mg | 28 | 24 | $0.00 |
| 47562 | 12 | 12 | $0.00 | |
| 83718 | 19 | 18 | $0.00 | |
| J9201 | Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 23 | 12 | $0.00 |
| C1874 | Stent, coated/covered, with delivery system | 42 | 39 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 707 | 346 | $0.00 |
| 87902 | 26 | 26 | $0.00 | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 23 | 12 | $0.00 |
| 78816 | 28 | 25 | $0.00 | |
| 93568 | 16 | 14 | $0.00 | |
| 77003 | 51 | 39 | $0.00 | |
| 38222 | 30 | 29 | $0.00 | |
| 66982 | 16 | 13 | $0.00 | |
| 94642 | 29 | 24 | $0.00 | |
| M0220 | Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring | 21 | 20 | $0.00 |
| 31624 | 15 | 14 | $0.00 | |
| J9310 | Injection, rituximab, 100 mg | 17 | 12 | $0.00 |
| 70360 | 15 | 15 | $0.00 | |
| 0042T | 13 | 13 | $0.00 | |
| 87207 | 15 | 13 | $0.00 | |
| 43246 | 12 | 12 | $0.00 | |
| P9041 | Infusion, albumin (human), 5%, 50 ml | 16 | 16 | $0.00 |
| J0689 | Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg | 14 | 12 | $0.00 |
| 36227 | 18 | 12 | $0.00 | |
| 88350 | 3,144 | 1,622 | $0.00 | |
| 99153 | Mod sedat endo service >5yrs | 3,887 | 3,602 | $0.00 |
| J2997 | Injection, alteplase recombinant, 1 mg | 2,369 | 1,831 | $0.00 |
| D0230 | Intraoral - periapical each additional radiographic image | 318 | 278 | $0.00 |
| 88311 | 770 | 662 | $0.00 | |
| 81277 | 213 | 182 | $0.00 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 1,085 | 1,043 | $0.00 |
| D1206 | Topical application of fluoride varnish | 1,084 | 795 | $0.00 |
| C1726 | Catheter, balloon dilatation, non-vascular | 1,215 | 1,115 | $0.00 |
| 96415 | 4,392 | 3,320 | $0.00 | |
| 36512 | 2,371 | 2,134 | $0.00 | |
| J0461 | Injection, atropine sulfate, 0.01 mg | 538 | 412 | $0.00 |
| 90474 | 3,084 | 3,062 | $0.00 | |
| 86664 | 386 | 379 | $0.00 | |
| J0586 | Injection, abobotulinumtoxina, 5 units | 1,136 | 964 | $0.00 |
| J9045 | Injection, carboplatin, 50 mg | 456 | 283 | $0.00 |
| C9285 | Lidocaine 70 mg/tetracaine 70 mg, per patch | 1,376 | 1,333 | $0.00 |
| 82952 | 332 | 321 | $0.00 | |
| J1097 | Phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml | 802 | 692 | $0.00 |
| 93505 | 817 | 592 | $0.00 | |
| C2617 | Stent, non-coronary, temporary, without delivery system | 386 | 359 | $0.00 |
| J1250 | Injection, dobutamine hydrochloride, per 250 mg | 258 | 233 | $0.00 |
| P9035 | Platelets, pheresis, leukocytes reduced, each unit | 165 | 75 | $0.00 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 610 | 577 | $0.00 |
| 86921 | 604 | 369 | $0.00 | |
| G0009 | Administration of pneumococcal vaccine | 638 | 633 | $0.00 |
| V2632 | Posterior chamber intraocular lens | 1,332 | 1,159 | $0.00 |
| 74174 | 260 | 250 | $0.00 | |
| J9312 | Injection, rituximab, 10 mg | 41 | 24 | $0.00 |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | 122 | 116 | $0.00 |
| D9420 | 509 | 370 | $0.00 | |
| 88264 | 250 | 200 | $0.00 | |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 116 | 76 | $0.00 |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 447 | 271 | $0.00 |
| G0010 | Administration of hepatitis b vaccine | 221 | 208 | $0.00 |
| 90480 | 254 | 250 | $0.00 | |
| J0185 | Injection, aprepitant, 1 mg | 797 | 535 | $0.00 |
| 88331 | 167 | 100 | $0.00 | |
| J9250 | Methotrexate sodium, 5 mg | 409 | 283 | $0.00 |
| 85303 | 19 | 16 | $0.00 | |
| 86687 | 78 | 63 | $0.00 | |
| A9503 | Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries | 98 | 89 | $0.00 |
| A4344 | Indwelling catheter, foley type, two-way, all silicone or polyurethane, each | 41 | 39 | $0.00 |
| 52000 | 97 | 91 | $0.00 | |
| J1459 | Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg | 156 | 54 | $0.00 |
| 94660 | 90 | 51 | $0.00 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 659 | 598 | $0.00 |
| 87147 | 272 | 259 | $0.00 | |
| 85097 | 55 | 36 | $0.00 | |
| J0178 | Injection, aflibercept, 1 mg | 125 | 105 | $0.00 |
| J2353 | Injection, octreotide, depot form for intramuscular injection, 1 mg | 31 | 24 | $0.00 |
| 84255 | 57 | 50 | $0.00 | |
| 82104 | 127 | 119 | $0.00 | |
| 96450 | 119 | 106 | $0.00 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 26 | 26 | $0.00 |
| 83550 | 4,249 | 3,994 | $0.00 | |
| J0485 | Injection, belatacept, 1 mg | 183 | 162 | $0.00 |
| J1950 | Injection, leuprolide acetate (for depot suspension), per 3.75 mg | 192 | 182 | $0.00 |
| 93531 | 134 | 104 | $0.00 | |
| C1892 | Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, peel-away | 313 | 278 | $0.00 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 240 | 205 | $0.00 |
| 93597 | 97 | 84 | $0.00 | |
| J1836 | Injection, metronidazole, 10 mg | 70 | 57 | $0.00 |
| 50200 | 45 | 41 | $0.00 | |
| J3411 | Injection, thiamine hcl, 100 mg | 47 | 37 | $0.00 |
| 91319 | 15 | 15 | $0.00 | |
| 86945 | 67 | 30 | $0.00 | |
| G8987 | Self care functional limitation, current status, at therapy episode outset and at reporting intervals | 96 | 74 | $0.00 |
| G8980 | Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting | 13 | 13 | $0.00 |
| G8982 | Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 85 | 76 | $0.00 |
| J9267 | Injection, paclitaxel, 1 mg | 91 | 46 | $0.00 |
| 93451 | 214 | 191 | $0.00 | |
| C1755 | Catheter, intraspinal | 40 | 37 | $0.00 |
| 96377 | 15 | 12 | $0.00 | |
| G8981 | Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals | 69 | 62 | $0.00 |
| G8988 | Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 98 | 75 | $0.00 |
| J9070 | Cyclophosphamide, 100 mg | 108 | 62 | $0.00 |
| G8998 | Swallowing functional limitation, discharge status, at discharge from therapy or to end reporting | 19 | 12 | $0.00 |
| 62367 | 13 | 12 | $0.00 | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 39 | 37 | $0.00 |
| 86905 | 47 | 42 | $0.00 | |
| 93463 | 14 | 12 | $0.00 | |
| C9463 | Injection, aprepitant, 1 mg | 30 | 25 | $0.00 |
| J0697 | Injection, sterile cefuroxime sodium, per 750 mg | 82 | 60 | $0.00 |
| 87158 | 66 | 62 | $0.00 | |
| Q0221 | Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 600 mg | 20 | 19 | $0.00 |
| 93458 | 63 | 52 | $0.00 | |
| 82553 | 23 | 13 | $0.00 | |
| J1805 | Injection, esmolol hydrochloride, 10 mg | 39 | 36 | $0.00 |
| 86826 | 17 | 12 | $0.00 | |
| 86593 | 72 | 69 | $0.00 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 26 | 24 | $0.00 |
| 29075 | 39 | 38 | $0.00 | |
| 86356 | 16 | 12 | $0.00 | |
| D0210 | Intraoral - complete series of radiographic images | 45 | 25 | $0.00 |
| 88239 | 118 | 103 | $0.00 | |
| 62370 | 21 | 16 | $0.00 | |
| 87176 | 14 | 13 | $0.00 | |
| C9290 | Injection, bupivacaine liposome, 1 mg | 12 | 12 | $0.00 |
| 85660 | 20 | 20 | $0.00 | |
| J2505 | Injection, pegfilgrastim, 6 mg | 21 | 12 | $0.00 |
| 93596 | 18 | 16 | $0.00 | |
| 86353 | 15 | 15 | $0.00 | |
| J0456 | Injection, azithromycin, 500 mg | 21 | 12 | $0.00 |
| 75820 | 45 | 44 | $0.00 | |
| Q0247 | Injection, sotrovimab, 500 mg | 26 | 25 | $0.00 |